Benjamin A. Lipsky

Dr. Benjamin A. Lipsky


Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2005 in JAMA
Verified
Journal Article
Open access
PDF file
NSNalini Singh
Nalini Singh
DADavid G. Armstrong
David G. Armstrong
BLBenjamin A. Lipsky
Benjamin A. Lipsky
ContextAmong persons diagnosed as having diabetes mellitus, the prevalence of foot ulcers is 4% to 10%, the annual population-based incidence is 1.0% to 4.1%,

15 June 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BLBenjamin A. Lipsky
Benjamin A. Lipsky
ABAnthony R. Berendt
Anthony R. Berendt
PCPaul B. Cornia
Paul B. Cornia
JPJames C. Pile
James C. Pile
EPEdgar JG Peters
Edgar JG Peters
ESEric Senneville
Eric Senneville
Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infection is defined by ≥2 classic findings of inflammation or purulence. Infections are then classified into mild (superficial and limited in size and depth), moderate (deeper or more extensive), or severe (accompanied by systemic signs or metabolic perturbations). This classification system, along with a vascular assessment, helps determine which patients should be hospitalized, which may require special imaging procedures or surgical interventions, and which will require amputation. Most DFIs are polymicrobial, with aerobic gram-positive cocci (GPC), and especially staphylococci, the most common causative organisms. Aerobic gram-negative bacilli are frequently copathogens in infections that are chronic or follow antibiotic treatment, and obligate anaerobes may be copathogens in ischemic or necrotic wounds.Wounds without evidence of soft tissue or bone infection do not require antibiotic therapy. For infected wounds, obtain a post-debridement specimen (preferably of tissue) for aerobic and anaerobic culture. Empiric antibiotic therapy can be narrowly targeted at GPC in many acutely infected patients, but those at risk for infection with antibiotic-resistant organisms or with chronic, previously treated, or severe infections usually require broader spectrum regimens. Imaging is helpful in most DFIs; plain radiographs may be sufficient, but magnetic resonance imaging is far more sensitive and specific. Osteomyelitis occurs in many diabetic patients with a foot wound and can be difficult to diagnose (optimally defined by bone culture and histology) and treat (often requiring surgical debridement or resection, and/or prolonged antibiotic therapy). Most DFIs require some surgical intervention, ranging from minor (debridement) to major (resection, amputation). Wounds must also be properly dressed and off-loaded of pressure, and patients need regular follow-up. An ischemic foot may require revascularization, and some nonresponding patients may benefit from selected adjunctive measures. Employing multidisciplinary foot teams improves outcomes. Clinicians and healthcare organizations should attempt to monitor, and thereby improve, their outcomes and processes in caring for DFIs.

1 October 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
BLBenjamin A. Lipsky
Benjamin A. Lipsky
ABAnthony R. Berendt
Anthony R. Berendt
HDH. Gunner Deery
H. Gunner Deery
JEJohn M. Embil
John M. Embil
WJWarren S. Joseph
Warren S. Joseph
JTJames S. Tan
James S. Tan

16 March 2020 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
BLBenjamin A. Lipsky
Benjamin A. Lipsky
Eric SennevilleEric Senneville
Eric Senneville
ZAZulfiqarali G. Abbas
Zulfiqarali G. Abbas
JAJavier Aragón-Sánchez
Javier Aragón-Sánchez
MDMathew Diggle
Mathew Diggle
O(on behalf of the International Working Group on the Diabetic Foot (IWGDF)
on behalf of the International Working Group on the Diabetic Foot (IWGDF)

1 June 2006 in Diabetes Care
Verified
Journal Article
Open access
PDF file
LLLawrence A. Lavery
Lawrence A. Lavery
DADavid G. Armstrong
David G. Armstrong
RWRobert P. Wunderlich
Robert P. Wunderlich
MMM. Jane Mohler
M. Jane Mohler
CWChristopher S. Wendel
Christopher S. Wendel
BLBenjamin A. Lipsky
Benjamin A. Lipsky
OBJECTIVE—To prospectively determine risk factors for foot infection in a cohort of people with diabetes.RESEARCH DESIGN AND METHODS—We evaluated then followed 1,666 consecutive diabetic patients enrolled in a managed care–based outpatient clinic in a 2-year longitudinal outcomes study. At enrollment, patients underwent a standardized general medical examination and detailed foot assessment and were educated about proper foot care. They were then rescreened at scheduled intervals and also seen promptly if they developed any foot problem.RESULTS—During the evaluation period, 151 (9.1%) patients developed 199 foot infections, all but one involving a wound or penetrating injury. Most patients had infections involving only the soft tissue, but 19.9% had bone culture–proven osteomyelitis. For those who developed a foot infection, compared with those who did not, the risk of hospitalization was 55.7 times greater (95% CI 30.3–102.2; P < 0.001) and the risk of amputation was 154.5 times greater (58.5–468.5; P < 0.001). Foot wounds preceded all but one infection. Significant (P < 0.05) independent risk factors for foot infection from a multivariate analysis included wounds that penetrated to bone (odds ratio 6.7), wounds with a duration >30 days (4.7), recurrent wounds (2.4), wounds with a traumatic etiology (2.4), and presence of peripheral vascular disease (1.9).CONCLUSIONS—Foot infections occur relatively frequently in individuals with diabetes, almost always follow trauma, and dramatically increase the risk of hospitalization and amputation. Efforts to prevent infections should be targeted at people with traumatic foot wounds, especially those that are chronic, deep, recurrent, or associated with peripheral vascular disease.

26 January 2016 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
BLBenjamin A. Lipsky
Benjamin A. Lipsky
JAJavier Aragón-Sánchez
Javier Aragón-Sánchez
MDMathew Diggle
Mathew Diggle
JEJohn Embil
John Embil
SKShigeo Kono
Shigeo Kono
EPEdgar JG Peters
Edgar JG Peters